Paid Clinical Trials in Little Rock, AR
As of August 2026, 495 paid clinical trials are recruiting in Little Rock, Arkansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Little Rock offers studies at sites including University of Arkansas for Medical Sciences for conditions such as Schizophrenia, Acute Myeloid Leukemia, Duchenne Muscular Dystrophy, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Little Rock
Trials by drug in Little Rock
Filter results
Newly added in Little Rock
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
449 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
A Study of Brenipatide in Adult Participants With Schizophrenia
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A Study of Brenipatide in Participants With Opioid Use Disorder
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
A Study of Brenipatide in Participants With Alcohol Use Disorder
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Pelacarsen Roll-over Extension Program
Top Research Study Locations in Little Rock
Researchers run research studies in Little Rock, AR at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Arkansas for Medical Sciences | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 104 |
| Arkansas Children's Hospital | Duchenne Muscular Dystrophy, Neuroblastoma, Acute Myeloid Leukemia | 91 |
| CARTI Cancer Center | Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Plasma Cell Myeloma | 31 |
| Arkansas Urology | Non-muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Benign Prostatic Hyperplasia | 13 |
| Woodland International Research Group | Alcohol Use Disorder, Bipolar Depression, Bipolar Disorder | 12 |
| Arkansas Children's Nutrition Center | Healthy, Adiposity, Blood Pressure | 10 |
| Applied Research Center of Arkansas | Thyroid Eye Disease, COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease | 10 |
| University of Arkansas | Breast Reconstruction, Cesarean Delivery, Diffuse Large B Cell Lymphoma (DLBCL) | 9 |
| Arkansas Children's Research Institute | Physical Activities, Duchene Muscular Dystrophy, High-grade Glioma | 8 |
| Arkansas Heart Hospital | Acute Myocardial Infarction, Aortic Valve Disease, Aortic Valve Stenosis | 6 |
| Pillar Clinical Research- Little Rock | Schizophrenia, Bipolar Disorder, Bipolar Disorder Type I With Mania | 6 |
| Arkansas Childrens Hospital | Duchenne Muscular Dystrophy, Eosinophilic Esophagitis (EoE), Medulloblastoma | 5 |
| Neurocrine Clinical Site | Major Depressive Disorder, Schizophrenia, Bipolar I Disorder | 5 |
| Pillar Clinical Research, LLC | Schizophrenia, Autism Spectrum Disorder, Bipolar Depression | 5 |
| Preferred Research Partners, Inc. | Attention-Deficit/Hyperactivity Disorder, Generalized Anxiety Disorder, Major Depressive Disorder | 5 |
| Arkansas Children's | B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia, B-Cell Lymphoblastic Leukemia | 4 |
| Arkansas Children's Hospital Research Institute | Adrenal Insufficiency, Arrythmia, Asthma in Children | 4 |
| Baptist Health Medical Center - Little Rock | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 4 |
| Lynn Institute of the Ozarks | Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Difficult to Control Hypertension | 4 |
| Arkansas Cardiology | Cryptogenic Stroke, Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | 3 |
| Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology | Allergy, Alpha-Gal Syndrome, Peanut Allergy | 3 |
| Arkansas Clinical Research | Acute Migraine, Migraine, Obesity | 3 |
| Central Arkansas Veterans Healthcare System , Little Rock, AR | Carcinoma, Hepatocellular, Cirrhosis, Liver Diseases | 3 |
| Clinical Trials, Inc. | Focal Epilepsy, Focal Onset Seizures | 3 |
| Pillar Clinical Research | Schizophrenia, Bipolar I Disorder | 3 |
Active & Upcoming Studies in Little Rock (2026)
Recruiting trials in Little Rock grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (138 active studies)
- A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · AbbVie
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC · Phase 3 · AstraZeneca
Mental health & behavior (38 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia · Phase 1 · Leal Therapeutics, Inc
Cardiovascular (29 active studies)
- Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation · Central Arkansas Veterans Healthcare System
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (27 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (23 active studies)
- Effect Of Whole or Skimmed Milk Greek Yogurt on Integrated Muscle Protein Synthesis, Glucose Homeostasis, and Cognition in Post-Menopausal Women · University of Arkansas
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Pediatric (11 active studies)
- Longitudinal Prospective Study of Maternal and Child Nutrition in Arkansas · Arkansas Children's Hospital Research Institute
- How Different Levels of CPAP Affect Oxygen Delivery and Lung Expansion in Preterm Infants · University of Arkansas
Vaccines (5 active studies)
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age · Phase 3 · GlaxoSmithKline
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults · Phase 1 · GlaxoSmithKline
HIV / STI (1 active study)
- Universal Basic Income and Structural Racism in the US South: HIV Care · University of Arkansas
Common conditions studied in Little Rock
- Schizophrenia (15 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Duchenne Muscular Dystrophy (10 active studies)
- Malignant Solid Neoplasm (8 active studies)
- Bipolar I Disorder (7 active studies)
- Endometrial Cancer (7 active studies)
Leading research sponsors in Little Rock
- University of Arkansas
- National Cancer Institute (NCI)
- Arkansas Children's Hospital Research Institute
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Little Rock?
There are approximately 495 recruiting clinical trials in Little Rock, Arkansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Little Rock pay participants?
Most recruiting trials in Little Rock compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Little Rock?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Little Rock?
The most common conditions under active study in Little Rock include Schizophrenia (15), Acute Myeloid Leukemia (11), Duchenne Muscular Dystrophy (10), Malignant Solid Neoplasm (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Little Rock?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Little Rock on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Little Rock?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Little Rock?
Recruiting research sites in Little Rock include University of Arkansas for Medical Sciences, Arkansas Children's Hospital, CARTI Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Little Rock right now?
The largest active categories in Little Rock are Cancer & tumors (138), Mental health & behavior (38), Cardiovascular (29). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.